2022
DOI: 10.1099/mic.0.001247
|View full text |Cite
|
Sign up to set email alerts
|

Extended genomic analyses of the broad-host-range phages vB_KmiM-2Di and vB_KmiM-4Dii reveal slopekviruses have highly conserved genomes

Abstract: High levels of antimicrobial resistance among members of the Klebsiella oxytoca complex (KoC) have led to renewed interest in the use of bacteriophage (phage) therapy to tackle infections caused by these bacteria. In this study we characterized two lytic phages, vB_KmiM-2Di and vB_KmiM-4Dii, that were isolated from sewage water against two GES-5-positive Klebsiella michiganensi… Show more

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
13
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
4
1

Relationship

3
2

Authors

Journals

citations
Cited by 7 publications
(14 citation statements)
references
References 75 publications
1
13
0
Order By: Relevance
“…The phage was screened against 56 clinical and 28 animal isolates representing a range of Klebsiella spp. ( K. michiganensis n=49, K. oxytoca n=25, K. grimontii n=9, K. huaxiensis n=1) [9, 21]. It did not infect the closely related K. michiganensis strains PS_Koxy1 and PS_Koxy4 [9].…”
Section: Resultsmentioning
confidence: 99%
See 4 more Smart Citations
“…The phage was screened against 56 clinical and 28 animal isolates representing a range of Klebsiella spp. ( K. michiganensis n=49, K. oxytoca n=25, K. grimontii n=9, K. huaxiensis n=1) [9, 21]. It did not infect the closely related K. michiganensis strains PS_Koxy1 and PS_Koxy4 [9].…”
Section: Resultsmentioning
confidence: 99%
“…vB_KmiS-Kmi2C did not infect animal isolates of Klebsiella spp. [21], but did infect some of the clinical K. oxytoca ( n =2) and K. michiganensis ( n =4) strains within our extended in-house collection [21] ( Table 1 ). From strain information provided by the Pathogen Bank (EUCAST testing) all these strains were resistant to amoxycillin, and sensitive to amikacin, ceftazidime, ceftazidime, ceftriaxone, cefuroxime, ciprofloxacin, ertapenem, gentamicin, meropenem, piptazobactam and trimethoprim.…”
Section: Resultsmentioning
confidence: 99%
See 3 more Smart Citations